Remove Behavioural Health Remove Development Remove FDA Approval Remove Research
article thumbnail

IVRHA 2022: Exhibiting pioneers of medical XR

pharmaphorum

In a crowd of 200 attendees, guests included medical XR start-ups, hospitals, and research universities from around the globe. In 2021, the behavioural health company and Sumitomo Dainippon Pharma Co.